Bentham Science Logo
Journal Cover

Track Your Manuscript:


Recent Patents on Anti-Cancer Drug Discovery

Volume 17, 4 Issues, 2022
ISSN: 2212-3970 (Online)
ISSN: 1574-8928 (Print)
This journal supports open access

Aims & Scope

Recent Patents on Anti-Cancer Drug Discovery publishes review/mini review and research articles that reflect or deal with studies in relation to a patent, application of reported patents in a study, discussion of comparison of results regarding application of a given patent, etc., and also guest edited thematic issues on recent patents in the field of anti-cancer drug discovery e.g. on novel bioactive compounds, analogs, targets & predictive biomarkers & drug efficacy biomarkers. The journal also publishes book reviews of eBooks and books on anti-cancer drug discovery. A selection of important and recent patents on anti-cancer drug discovery is also included in the journal. The journal is essential reading for all researchers involved in anti-cancer drug design and discovery. The journal also covers recent research (where patents have been registered) in fast emerging therapeutic areas/targets & therapeutic agents related to anti-cancer drug discovery.

Recent Patents on Anti-Cancer Drug Discovery

,

Volume 16

-

Number 4






Review Article



Review Article

Ultrasound-Mediated Cancer Therapeutics Delivery using Micelles and Liposomes: A Review

, 16(4): 498 - 520

Debasmita Mukhopadhyay, Catherine Sano, Nour AlSawaftah, Raafat El-Awady, Ghaleb A. Husseini* and Vinod Paul


DOI: 10.2174/1574892816666210706155110


Research Article



Research Article



Research Article



Recent Patents on Anti-Cancer Drug Discovery, Volume 17 (2022) - Number 1


This issue is in progress but contains articles that are final and fully citable.

Articles Ahead of Print

The Validity of Mobile Applications to Facilitate Patient Care Provided to Cancer Patients: Opportunities and Limitations


Haneen Amawi*, Sayer Al-Azzam, Tasnim Alzanati , Neveen Altamimi, Alaa Hammad , Karem H. Alzoubi , Jr. Charles R. Ashby and Amit K. Tiwari


DOI: 10.2174/1574892816666210728122304
View Abstract View on PubMed








Abstracts Ahead of Print




β-Estradiol Induces Mitochondrial Apoptosis in Cervical Cancer Through the Suppression of AKT/NF-κB Signaling Pathway


Yuqing Huang, Shouguo Chen, Yuhe Lei, Chiwing Chung, Meiching Chan, Lei Chen, Yinqin Zhong, Enxin Zhang*, Jiaxu Chen* and Lijuan Deng*


DOI: 10.2174/1574892817666211222150409
View Abstract





Recent Progress in Natural Anticancer Agents Discovery from Tea (Camellia sinensis): A Review


Jingna Zhou, Ruilin Li, Yanan Jia, Yajie Wang, Junyu Liu, Pharkphoom Panichayupakaranant and Haixia Chen*


DOI: 10.2174/1574892816666211208155811
View Abstract




Published Contents

Editor's Choice


STAT3 Inhibitor Napabucasin Inhibits Tumor Growth and Cooperates with Proteasome Inhibition in Human Ovarian Cancer Cells

, 2021; 16(3): 350 - 362

Yao Liu, Xiaolin Peng, Hui Li, Wenhui Jiao, Xin Peng, Jingrong Shao, Yanglu Xu, Ran Wang*, Wei Wang* and Dexin Kong*


DOI: 10.2174/1574892816666210224155403



Repurposing of Metformin for Cancer Therapy: Updated Patent and Literature Review

, 2021; 16(2): 161 - 186

Zainab Sabry Othman Ahmed, Matthew Golovoy, Yassen Abdullah, Reda Saber Ibrahim Ahmed and Q. Ping Dou*


DOI: 10.2174/1574892816666210615163417







Feasibility of Repurposing Clioquinol for Cancer Therapy

, 2020; 15(1): 14 - 31

Raheel Khan, Harras Khan, Yassen Abdullah and Q. Ping Dou*


DOI: 10.2174/1574892815666200227090259




HMGA and Cancer: A Review on Patent Literatures

, 2019; 14(3): 258 - 267

Marco De Martino, Alfredo Fusco and Francesco Esposito*


DOI: 10.2174/1574892814666190919152001



Most Cited Articles

Review Article

Repurposing disulfiram as an anti-cancer agent: Updated review on literature and patents

, 2019; 14(2): 113-132.

Elmira Ekinci, Sagar Rohondia, Raheel Khan and Qingping P. Dou*


DOI: 10.2174/1574892814666190514104035


Review Article

Tobacco smoking: Risk to develop addiction, chronic obstructive pulmonary disease, and lung cancer

, 2019; 14(1): 39-52.

Alessia Santoro, Carlo Tomino, Giulia Prinzi, Palma Lamonaca, Vittorio Cardaci, Massimo Fini and Patrizia Russo*


DOI: 10.2174/1574892814666190102122848


Review Article

New anti-cancer strategies in testicular germ cell tumors

, 2019; 14(1): 53-59.

Paolo Chieffi*, Marco De Martino and Francesco Esposito


DOI: 10.2174/1574892814666190111120023


General Review Article

HMGA and cancer: A review on patent literatures

, 2019; 14(3): 258-267.

Marco De Martino, Alfredo Fusco and Francesco Esposito*


DOI: 10.2174/1574892814666190919152001


Research Article

A truncated snail1 transcription factor alters the expression of essential EMT markers and suppresses tumor cell migration in a human lung cancer cell line

, 2019; 14(2): 158-169.

Mohammad Davoodzadeh Gholami, Reza Falak*, Sahel Heidari, Majid Khoshmirsafa, Mohammad H. Kazemi, Amir-Hassan Zarnani, Elaheh Safari, Nader Tajik and Gholam A. Kardar*


DOI: 10.2174/1574892814666190527111429


Review Article

Cucurbitacins as anticancer agents: A patent review

, 2019; 14(2): 133-143.

Hidayat Hussain*, Ivan R. Green, Muhammad Saleem, Khanzadi F. Khattak, Muhammad Irshad and Maroof Ali


DOI: 10.2174/1574892813666181119123035


Review Article

Tocotrienols and cancer: From the state of the art to promising novel patents

, 2019; 14(1): 5-18.

Fabrizio Fontana, Michela Raimondi, Monica Marzagalli, Roberta M. Moretti, Marina Montagnani Marelli and Patrizia Limonta*


DOI: 10.2174/1574892814666190116111827


Review Article

From antimicrobial to anticancer peptides: The transformation of peptides

, 2019; 14(1): 70-84.

Yuan Qin, Zuo D. Qin, Jing Chen, Che G. Cai, Ling Li, Lu Y. Feng, Zheng Wang, Gregory J. Duns, Nong Y. He, Zhe S. Chen* and Xiao F. Luo*


DOI: 10.2174/1574892814666190119165157


Review Article (Mini-Review)

Developments in the application of 1,2,3-triazoles in cancer treatment

, 2020; 15(2): 92-112.

Katerina I. Slavova, Lozan T. Todorov*, Nataliya P. Belskaya, Mauricio A. Palafox and Irena P. Kostova


DOI: 10.2174/1574892815666200717164457




Review Article

Contemporary formulations for drug delivery of anticancer bioactive compounds

, 2019; 14(1): 19-31.

Darinka G. Ackova, Katarina Smilkov and Darko Bosnakovski*


DOI: 10.2174/1574892814666190111104834


Review Article

MDM2-P53 interaction inhibitors: The current state-of-art and updated patent review (2010-present)

, 2019; 14(4): 324-369.

Rafał Rusiecki, Jakub Witkowski* and Jaszczewska-Adamczak Joanna


DOI: 10.2174/1574892814666191022163540


General Review Article

Natural product as substrates of abc transporters: A review

, 2021; 16(2): 222-238.

Xuan-Yu Chen, Jing-Quan Wang, Yuqi Yang, Jing Li* and Zhe-Sheng Chen*


DOI: 10.2174/1574892816666210218220943


Review Article (Mini-Review)

Alkaloids as anticancer agents: A review of chinese patents in recent 5 years

, 2020; 15(1): 2-13.

Hongyu Tao, Ling Zuo, Huanli Xu, Cong Li, Gan Qiao, Mingyue Guo and Xiukun Lin*


DOI: 10.2174/1574892815666200131120618



Most Accessed Articles

Pseudo-ginsenoside Rh2 Induces Protective Autophagy in Hepatocellular Carcinoma HepG2 Cells

, 2021; 16(4): 521-532.

Fuyuan Zhang, Huali Xu, Rui Xia, Ping Yu, Yuangeng Li, Xiaofeng Yu and Dayun Sui*


DOI: 10.2174/1574892816666210607100239


Ultrasound-Mediated Cancer Therapeutics Delivery using Micelles and Liposomes: A Review

, 2021; 16(4): 498-520.

Debasmita Mukhopadhyay, Catherine Sano, Nour AlSawaftah, Raafat El-Awady, Ghaleb A. Husseini* and Vinod Paul


DOI: 10.2174/1574892816666210706155110




STAT3 Inhibitor Napabucasin Inhibits Tumor Growth and Cooperates with Proteasome Inhibition in Human Ovarian Cancer Cells

, 2021; 16(3): 350-362.

Yao Liu, Xiaolin Peng, Hui Li, Wenhui Jiao, Xin Peng, Jingrong Shao, Yanglu Xu, Ran Wang*, Wei Wang* and Dexin Kong*


DOI: 10.2174/1574892816666210224155403


Human Saliva Metabolome for Oral Lichen Planus Biomarker Identification

, 2021; 16(3): 417-425.

Xiaoshuang Wang, Liwei Liu, Qiuzheng Du, Zhi Sun, Erli Yue, Peng Xue* and Hongyu Zhao*


DOI: 10.2174/1574892816666210224160120



BCR-ABL Transcript Level as Compared to LDH and Uric Acid Among Chronic Myeloid Leukemic Patients

, 2021; 16(3): 445-455.

Temesgen Sisay Hailemariam, Mohammed Mehdi*, Samuel Kinde, Daniel Seifu and Abebe Edao


DOI: 10.2174/1574892816666210222152126





The Anti-Tumor Mechanism and Target of Triptolide Based on Network Pharmacology and Molecular Docking

, 2021; 16(3): 426-435.

Tao Zou, Yuanqiong Huang, Yifan Hu, Mingyu Wu, Yueshui Zhao, Fukuan Du, Mingxing Li, Xu Wu, Huijioa Ji, Parham Jabbarzadeh Kaboli, Shurong Wang, Zhangang Xiao* and Zhigui Wu*


DOI: 10.2174/1574892816666210211143059







Editor-in-Chief

graphic
Zhe-Sheng (Jason) Chen
Institute for Biotechnology
College of Pharmacy and Health Sciences
St. John's University
New York, NY
(USA)
Biography
View Full Editorial Board

COPE Compliant

Cope Logo

Journal History

Recent Patents on Anti-Cancer Drug Discovery was launched in 2006. Prof. Zhe-Sheng (Jason) Chen serves as the Editor-in-Chief of the journal.

Related Journals

Related eBooks

eBooks Catalog